The present invention relates to the compound presented by formula (I) 1
(wherein all symbols in formula (I) are the same mean as the description
shown in the specification.), mitocondorial benzogeazepin receptor (MBR)
antagonist comprising the compound, the preventive and/or treatment
medicine against diseases caused by stress of which an active ingredient
is the compound.
Since the compound represented by formula (I) has MBR antagonistic
activity, and controls the production of neurosteroid, it is useful as
the preventive and/or treatment medicine against diseases caused by
stress.
